Detalhe da pesquisa
1.
Erythrodermic psoriasis successfully and rapidly treated with brodalumab: Report of two cases.
Dermatol Ther;
33(6): e14351, 2020 11.
Artigo
em Inglês
| MEDLINE
| Set 2020
| ID: mdl-32981222
2.
A case of erythrodermic psoriasis successfully treated with ixekizumab.
Dermatol Ther;
32(2): e12825, 2019 03.
Artigo
em Inglês
| MEDLINE
| Jan 2019
| ID: mdl-30650216
3.
Reply to 'Nail psoriasis: A rare mRNA COVID-19 vaccine reaction' by Lamberti A et al.
J Eur Acad Dermatol Venereol;
37(1): e41-e42, 2023 01.
Artigo
em Inglês
| MEDLINE
| 2023
| ID: mdl-35989613
4.
A case of esophageal candidiasis in a psoriatic patient treated with ixekizumab: Should treatment be discontinued?
Dermatol Ther;
35(4): e15361, 2022 04.
Artigo
em Inglês
| MEDLINE
| Fev 2022
| ID: mdl-35137503
5.
Tildrakizumab: A new therapeutic option for erythrodermic psoriasis?
Dermatol Ther;
34(5): e15030, 2021 09.
Artigo
em Inglês
| MEDLINE
| Jun 2021
| ID: mdl-34137492
6.
Ixekizumab: An efficacious treatment for both psoriasis and hidradenitis suppurativa.
Dermatol Ther;
33(4): e13756, 2020 07.
Artigo
em Inglês
| MEDLINE
| Jun 2020
| ID: mdl-32495491
7.
Pityriasis Rosea and Pityriasis Rosea-Like Eruption Following COVID-19 Vaccination: A Narrative Review.
Clin Cosmet Investig Dermatol;
17: 51-57, 2024.
Artigo
em Inglês
| MEDLINE
| Jan 2024
| ID: mdl-38222859
8.
Concomitant Severe Psoriasis and Bullous Pemphigoid Induced by COVID-19.
Trop Med Infect Dis;
8(2)2023 Feb 08.
Artigo
em Inglês
| MEDLINE
| Fev 2023
| ID: mdl-36828523
9.
Herpes Zoster and COVID-19 Vaccination: A Narrative Review.
Clin Cosmet Investig Dermatol;
16: 3323-3331, 2023.
Artigo
em Inglês
| MEDLINE
| Nov 2023
| ID: mdl-38021418
10.
Drug safety evaluation of tildrakizumab for psoriasis: a review of the current knowledge.
Expert Opin Drug Saf;
21(12): 1445-1451, 2022 Dec.
Artigo
em Inglês
| MEDLINE
| Dez 2022
| ID: mdl-36527300
11.
Assessment of the efficacy, skin acceptability and cosmetic quality of an adjuvant cream based on 40% urea and amino-inositol in the treatment of mild psoriasis.
Ital J Dermatol Venerol;
157(6): 515-519, 2022 Dec.
Artigo
em Inglês
| MEDLINE
| 2022
| ID: mdl-36651204
12.
Matching-adjusted indirect comparison of efficacy outcomes in trials of calcipotriol plus betamethasone dipropionate foam and cream formulations for the treatment of plaque psoriasis.
J Dermatolog Treat;
33(7): 3005-3013, 2022 Nov.
Artigo
em Inglês
| MEDLINE
| Jul 2022
| ID: mdl-35875991
13.
The Role of Teledermatology During the COVID-19 Pandemic: A Narrative Review.
Clin Cosmet Investig Dermatol;
15: 2785-2793, 2022.
Artigo
em Inglês
| MEDLINE
| Dez 2022
| ID: mdl-36569420
14.
Long-term proactive management of psoriasis with calcipotriol and betamethasone dipropionate foam: an Italian consensus through a combined nominal group technique and Delphi approach.
Int J Dermatol;
61(12): 1543-1551, 2022 Dec.
Artigo
em Inglês
| MEDLINE
| Maio 2022
| ID: mdl-35609147
15.
A case of psoriatic alopecia secondary to certolizumab pegol: clinical and trichoscopic evaluation.
Int J Dermatol;
62(2): e70-e72, 2023 02.
Artigo
em Inglês
| MEDLINE
| 2023
| ID: mdl-35579302
16.
Long-term results of teledermatology for acne patients during COVID-19 pandemic.
J Cosmet Dermatol;
21(4): 1356-1357, 2022 04.
Artigo
em Inglês
| MEDLINE
| Jan 2022
| ID: mdl-35090188
17.
Medical and Surgical Treatment of Hidradenitis Suppurativa: A Review.
Skin Appendage Disord;
3(2): 95-110, 2017 May.
Artigo
em Inglês
| MEDLINE
| Jun 2017
| ID: mdl-28560220
18.
Chronic inflammatory skin diseases and biologics: what to expect after COVID-19 pandemic?
Int J Dermatol;
59(9): 1144-1145, 2020 Sep.
Artigo
em Inglês
| MEDLINE
| Jul 2020
| ID: mdl-32710548
19.
COVID-19 pandemic: University of Naples Federico II Dermatology's model of dermatology reorganization.
Int J Dermatol;
59(7): e239-e240, 2020 Jul.
Artigo
em Inglês
| MEDLINE
| Maio 2020
| ID: mdl-32358978
20.
Pyoderma gangrenosum successfully treated with topical tacrolimus.
G Ital Dermatol Venereol;
154(3): 361-363, 2019 Jun.
Artigo
em Inglês
| MEDLINE
| 2019
| ID: mdl-29368849